Both histamine H2-receptor antagonists and gastric proton pump inhibitors are now world-widely used as the first choice for the treatment of acid-related diseases.
This report contains market size and forecasts of Gastric Antisecretory Drug in global, including the following market information:
Global Gastric Antisecretory Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastric Antisecretory Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gastric Antisecretory Drug companies in 2021 (%)
The global Gastric Antisecretory Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
H2-receptor Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastric Antisecretory Drug include Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda and NCPC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastric Antisecretory Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Antisecretory Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Type, 2021 (%)
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others
Global Gastric Antisecretory Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, by Application, 2021 (%)
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others
Global Gastric Antisecretory Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastric Antisecretory Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Antisecretory Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastric Antisecretory Drug revenues share in global market, 2021 (%)
Key companies Gastric Antisecretory Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gastric Antisecretory Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin